関連する実験動画
Updated: May 5, 2026
08:30
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
Published on: April 19, 2011
23.6K
人間の血小板アデノシンA(2A) 受容体に対するカフェインの摂取量と時間の影響:機能的および生化学的側面
K Varani1, F Portaluppi, S Gessi
1Department of Clinical and Experimental Medicine, University of Ferrara, Italy.
Circulation
|July 19, 2000
まとめ
慢性的なカフェイン摂取は,ヒトの血小板のアデノシンA2A受容体を調節する. これは,アゴニストHE-NECAに対する感受性の増加につながり,cAMPレベルと血小板の集積に影響を及ぼします.
科学分野:
- 薬理学 薬理学とは
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
背景:
- アデノシンA(2A) 受容体は,血小板機能に役割を果たしています.
- カフェインは広く消費される刺激剤で,受容体発現に潜在的影響を及ぼします.
研究 の 目的:
- 慢性的なカフェイン投与がヒトの血小板アデノシンA2A受容体に及ぼす影響を調査する.
- カフェインがA(2A) 受容体を高調化し,アゴニスト刺激に対する細胞の反応を変化させるかどうかを判断する.
主な方法:
- 健康なボランティアは,様々な量のカフェインを服用し,服用期間も様々でした.
- 血小板受容体発現,cAMP蓄積,および集積を測定しました.
- [(3) H] SCH 58261を用いた放射性リンガンド結合測定が行われました.
主要な成果:
- 14日間400 mg/日,または7日間600 mg/日というカフェインの投与量は,A2A受容体を上調する.
- アゴニストであるHE-NECAは,抗集積効果,cAMP蓄積,およびカルシウム減少における効能の増加を示した.
- 低用量 (400 mg/日7日間) は有意な効果を示さなかった.
結論:
- 慢性的なカフェイン摂取は,血小板のアデノシンA (Adenosine A) 2A受容体を,投与量と時間によって上位に調節する.
- アデノシンA2A受容体アゴニストに対する細胞反応の強化と関連している.
- これは,血小板シグナル伝達経路にカフェインが及ぼす影響を示唆しています.
関連する概念動画
01:14Time Course of Drug Effect
2.6K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.6K
01:27Adrenergic Receptors (Adrenoceptors): Classification
4.9K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
4.9K
01:31Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K